Shearman & Sterling LLP multinational law firm headquartered in New York City, United States.

balance scale

May 03, 2016

Lilienfeld, Polovoy and Kessel Weigh in on Delaware Director Compensation Cases

Subscribe

Jump to...

 
To successfully defend legal challenges against compensation committee decisions, biopharmaceutical companies must make greater efforts to obtain the necessary approvals from stockholders.  Healthcare industry partners Doreen Lilienfeld, Brian Polovoy and Mark Kessel co-authored a letter to the editor on this subject that was published in Nature Biotechnology. According to the authors, biopharmaceutical companies will ignore the Delaware director compensation cases at their own peril.

View full article, Delaware Director Compensation Cases

Authors and Contributors

Doreen E. Lilienfeld

Partner

Compensation, Governance & ERISA

+1 212 848 7171

+1 212 848 7171

+1 650 838 3804

+1 650 838 3804

New York

Brian H. Polovoy

Partner

Litigation

+1 212 848 4703

+1 212 848 4703

New York

Mark Kessel

Of Counsel

Capital Markets

+1 212 848 4416

+1 212 848 4416

New York